Literature DB >> 23133182

Thoracic cancers - cautious optimism replaces abject nihilism.

C S Pramesh1.   

Abstract

Entities:  

Year:  2010        PMID： 23133182      PMCID： PMC3452738          DOI： 10.1007/s12262-009-0085-5

Source DB:  PubMed          Journal:  Indian J Surg        ISSN： 0973-9793            Impact factor:   0.656


× No keyword cloud information.
  8 in total

Review 1.  Targeted therapy for advanced non-small cell lung cancers: historical perspective, current practices, and future development.

Authors:  Devalingam Mahalingam; Alain Mita; Monica M Mita; Steffan T Nawrocki; Francis J Giles
Journal:  Curr Probl Cancer       Date:  2009 Mar-Apr       Impact factor: 3.187

2.  Lobectomy versus limited resection in T1 N0 lung cancer.

Authors:  F A Lederle
Journal:  Ann Thorac Surg       Date:  1996-10       Impact factor: 4.330

Review 3.  Postoperative radiotherapy for non-small cell lung cancer.

Authors: 
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

4.  Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.

Authors:  Brian E Lally; Daniel Zelterman; Joseph M Colasanto; Bruce G Haffty; Frank C Detterbeck; Lynn D Wilson
Journal:  J Clin Oncol       Date:  2006-06-12       Impact factor: 44.544

5.  Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

Authors:  Val Gebski; Bryan Burmeister; B Mark Smithers; Kerwyn Foo; John Zalcberg; John Simes
Journal:  Lancet Oncol       Date:  2007-03       Impact factor: 41.316

6.  A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer.

Authors:  Yi long Wu; Zhi-fan Huang; Si-yu Wang; Xue-ning Yang; Wei Ou
Journal:  Lung Cancer       Date:  2002-04       Impact factor: 5.705

7.  Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial.

Authors:  Mark S Allen; Gail E Darling; Taine T V Pechet; John D Mitchell; James E Herndon; Rodney J Landreneau; Richard I Inculet; David R Jones; Bryan F Meyers; David H Harpole; Joe B Putnam; Valerie W Rusch
Journal:  Ann Thorac Surg       Date:  2006-03       Impact factor: 4.330

8.  Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

Authors:  Jean-Pierre Pignon; Hélène Tribodet; Giorgio V Scagliotti; Jean-Yves Douillard; Frances A Shepherd; Richard J Stephens; Ariane Dunant; Valter Torri; Rafael Rosell; Lesley Seymour; Stephen G Spiro; Estelle Rolland; Roldano Fossati; Delphine Aubert; Keyue Ding; David Waller; Thierry Le Chevalier
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.